Latham & Watkins LLP represented Immuneering Corporation in the transaction. Immuneering Corporation has announced the completion of an oversubscribed US$62 million Series B financing led by…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now